Punt J A, Suzuki H, Granger L G, Sharrow S O, Singer A
Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
J Exp Med. 1996 Dec 1;184(6):2091-9. doi: 10.1084/jem.184.6.2091.
Lineage commitment is a developmental process by which individual CD4+CD8+ (double positive, DP) thymocytes make a decision to differentiate into either CD4+ or CD8+ T cells. However, the molecular event(s) that defines lineage commitment is controversial. We have previously proposed that lineage commitment in DP thymocytes can be molecularly defined as the selective termination of CD4 or CD8 coreceptor synthesis. The present study supports such a molecular definition by showing that termination of either CD4 or CD8 synthesis is a highly regulated event that is only evident within the most differentiated DP subset (CD5hiCD69hiTCRhibcl-2hi). In fact, essentially all cells within this DP subset actively synthesize only one coreceptor molecule. In addition, the present results identify three distinct sub-populations of DP thymocytes that define the developmental progression of the lineage commitment process and demonstrate that lineage commitment is coincident with upregulation of TCR and bcl-2. Thus, this study supports a molecular definition of lineage commitment and uniquely identifies TCRhibcl-2hi DP thymocytes as cells that are already committed to either the CD4 or CD8 T cell lineage.
谱系定向是一个发育过程,通过这个过程,单个CD4+CD8+(双阳性,DP)胸腺细胞决定分化为CD4+或CD8+T细胞。然而,定义谱系定向的分子事件存在争议。我们之前提出,DP胸腺细胞中的谱系定向在分子层面可定义为CD4或CD8共受体合成的选择性终止。本研究通过表明CD4或CD8合成的终止是一个高度受调控的事件,且仅在最分化的DP亚群(CD5hiCD69hiTCRhibcl-2hi)中明显,支持了这样一种分子定义。事实上,这个DP亚群中的几乎所有细胞仅积极合成一种共受体分子。此外,本研究结果确定了DP胸腺细胞的三个不同亚群,它们定义了谱系定向过程的发育进程,并证明谱系定向与TCR和bcl-2的上调同时发生。因此,本研究支持谱系定向的分子定义,并独特地将TCRhibcl-2hi DP胸腺细胞鉴定为已定向至CD4或CD8 T细胞谱系的细胞。